Publikace
- Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate2024 | Lékařská fakulta v Plzni
- Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience2023 | Lékařská fakulta v Plzni
- Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib2021 | Lékařská fakulta v Plzni, 1. lékařská fakulta
- Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line2021 | Lékařská fakulta v Plzni, 1. lékařská fakulta
- The Predictive Role of Primary Tumour Sidedness in Metastatic Colorectal Cancer Treated With Targeted Agents2019 | Lékařská fakulta v Plzni, 1. lékařská fakulta
- Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients2019 | Lékařská fakulta v Plzni, 1. lékařská fakulta
- Systémová onkologická léčba hepatocelulárního karcinomu2019 | Lékařská fakulta v Plzni
- The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line2018 | Lékařská fakulta v Plzni, 1. lékařská fakulta
- Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC2017 | Lékařská fakulta v Plzni, 1. lékařská fakulta, Přírodovědecká fakulta
- Imunoterapie v léčbě karcinomu plic2017 | Lékařská fakulta v Plzni, 1. lékařská fakulta
Loading network view...